Permalink | Email this | Linking Blogs | Comments

According to the article: "I would not be averse to a Fed-assisted transaction," Stumpf said, adding that any deal would have to meet the company's traditional acquisition targets and benefit the bank's acquired customers. Wells has built a reputation as a disciplined buyer over the years, focusing on deals that generate at least a 15% internal rate of return and contribute to the bottom line within three years.

"Fixer-uppers don't bother us," he added.

Who wouldn't want to be part of a deal like this? It's become pretty obvious that JP Morgan Chase got an amazing deal to buy Bear Stearns, and now Wells Fargo wants to join the party.

If Wells Fargo is able to swing a great deal by buying some large and beleaguered financial company for less than that company's building is worth, like what happened with Bear Stearns, then investors may want to take a long hard look at Wells Fargo stock. This may be the potential catalyst needed to drive the stock up in the coming months.

Aaron Katsman is the lead Portfolio Manager and Managing Director of America Israel Investment Associates, LLC. and Senior Editor of IsraelNewsletter.com. DISCLOSURE: Writer's fund has no position in any stock mentioned, as of 3/25/08

Read | Permalink | Email this | Linking Blogs | Comments

Here are some highlights from this past week's earnings coverage from BloggingStocks:

• Analogic Corp. (NASDAQ: ALOG) beat estimates and announced an acquisition.
• AnnTaylor Stores Corp. (NYSE: ANN) swung to a loss in the fourth quarter on restructuring costs.
• Big Lots Inc. (NYSE: BIG) beat fourth-quarter earinings estimates and offered revised guidance.
• Bon-Ton Stores Inc. (NASDAQ: BONT) posted disappointing fourth-quarter and full-year results.
• Carrols Restaurant Group (NASDAQ: TAST) posted solid results on same-store sales for certain chains.
• Ferrellgas Partners (NYSE: FGP) saw profit fall in what should have been its strongest quarter.
• Foot Locker Inc. (NYSE: FL) fourth-quarter profit fell on weaker same-store sales.
• Humana Inc. (NYSE: HUM) cut its first-quarter and full-year forecasts on higher expenses.
• Imax Corp. (NASDAQ: IMAX) widened its losses for the fourth quarter and the full year.
• Jones Soda Co. (NASDAQ: JSDA) swung to a loss due to costs related to distributing in product in cans.
• K-Tron International Inc. (NASDAQ: KTII) said fourth-quarter and full-year earnings soared.
• Liz Claiborne Inc. (NYSE: LIZ) posted disappointing fourth-quarter and full-year results.
• Six Flags Inc. (NYSE: SIX) narrowed its fourth-quarter and full-year losses.
• Texas Instruments Inc. (NYSE: TXN) lowered its forecast on fewer orders from a key client.
• United Parcel Service (NYSE: UPS) warned it may miss first quarter estimates due to the slowing economy.
• Vail Resorts Inc. (NYSE: MTN) second-quarter profit slipped due to lack of snow early in the season.

Also, analysts are pessimistic about earnings for the first half of the year. Jim Cramer sees earnings as the other shoe after good news from the Fed, and things look grim for auto makers as well as for smaller companies. At least one analyst expects a big earnings miss from Google Inc. (NASDAQ: GOOG). Target's (NYSE: TGT) moves into consumer credit may come back to hurt its first-quarter results. But some analysts are bullish about Nike Inc. (NYSE: NKE) ahead of earings next week. Georges Yared wonders if Wal-Mart's (NYSE: WMT) earnings make it a good buy for the long term. And the SEC may change reporting rules for financial firms.

Upcoming results to watch for include Goldman Sachs (NYSE: GS), Lehman Bros. (NYSE: LEH), Morgan Stanley (NYSE: MS), Bear Stearns (NYSE: BSC), Nike (NYSE: NKE), General Mills (NYSE: GIS), FedEx (NYSE: FDX), Barnes & Noble (NYSE: BKS),

Visit AOL Money & Finance for more earnings coverage.

Permalink | Email this | Linking Blogs | Comments

Jones Soda (NASDAQ: JSDA) is off over 24% on weak earnings.

Aetna (NYSE: AET) is off over 6% on a poor outlook for 2008.

Nokia (NYSE: NOK) is off over 5% on concerns that Texas Intruments (NYSE: TXN) chip shipments show a slowdown in handset sales.

WellPoint (NYSE: WLP) is trading down over 15% on an analyst cut.

Stocks may trade differently in the pre-market than they do in the regular session.

Douglas A. McIntyre is an editor at 247wallst.com.

Permalink | Email this | Linking Blogs | Comments

Athletic apparel retailer Foot Locker Inc. (NYSE: FL) reported that its fourth-quarter profit dropped 23% due to a shorter fiscal year and a drop in same-store sales. Net income fell to $87 million, or 56 cents per share, but after adjustments the company said it earned 23 cents per share in the latest quarter. Revenue fell 10% to $1.48 billion. Analysts polled by Thomson Financial had expected earnings of 44 cents per share on revenue of $1.48 billion.

The company said its same-store sales fell 7.8% percent in the quarter, and noted that the year-ago quarter included an extra week.

For the full year, profit fell 79% to $53 million, or 34 cents per share, from $251 million, or $1.60 per share, in the prior year. Full-year revenue dropped 4% to $5.44 billion from $5.75 billion in 2006.

Foot Locker shares fell 9 cents to close at $11.15, but rose to $11.30 in after-hours trading.

Soda maker Jones Soda Co. (NASDAQ: JSDA) reported that it swung to a fourth-quarter loss due to higher fees and costs related to plans to sell soda in cans.

The company reported a loss of $10.2 million, or 39 cents per share, for the quarter that ended December 31, compared to a profit of $2.1 million, or 8 cents per share, in the year-ago period. Excluding a valuation allowance, the company reported a loss of 18 cents per share. Revenue fell 41% percent to $5.9 million. Analysts polled by Thomson Financial had expected a loss of only 3 cents per share on revenue of $9.7 million.

For the full year, the company swung to a loss of $11.6 million, or 45 cents per share, compared to a profit of $4.6 million, or 19 cents per share, in the prior year. Revenue grew 2% to $39.8 million.

Jones Soda shares fell 27 cents, or 5.9%, to close at $4.34, but continued to fall to $3.30 in after-hours trading.

Visit AOL Money & Finance for more earnings coverage.

Permalink | Email this | Linking Blogs | Comments

• Boeing (NYSE: BA) was upgraded by Bernstein from Market Perform to Outperform. However, Boeing said this morning, PrivatAir has ordered an additional 787-model airplane for $162 million.
• Adobe Systems (NASDAQ: ADBE) and McAfee (NYSE: MFE) were downgraded from Buy to Neutral by UBS.
• Harley Davidson (NYSE: HOG) was downgraded by Citigroup from Hold to Sell. Shares down over 4% in premarket trading.
  
• Intel Corp. (NASDAQ: INTC) was downgraded by Charter Equity from Buy to Market Perform.
• Oppenheimer downgraded JPMorgan Chase (NYSE: JPM) and Wells Fargo (NYSE: WFC) from Outperform to Perform.
• Piper Jaffray downgraded Jones Soda (NASDAQ: JSDA) from Buy to Neutral. Shares down over 3% in premarket trading.
  
• Friedman Billings, with its Outperform rating on Alcoa (NYSE: AA), lowered the aluminum maker's target price from $38 to $35.
• Altria (NYSE: MO)'s target price was upped to $88 from $79 by Credit Suisse, which rates the stock Outperform.

Permalink | Email this | Linking Blogs | Comments

MOST NOTEWORTHY:

• Merriman assumed coverage of Jones Soda (NASDAQ:JSDA) with a Neutral rating and believes shares will languish until interim management resets expectations. For FY08, they expect sales to grow 25%-30%, rather than the consensus estimate of 38%.
  
• Jefferies thinks Whiting Petroleum (NYSE:WLL) is entering a multi-year organic and sees catalysts from the upcoming Bakken well results and positive production response from Enhanced Oil Resources (EOR) projects. The firm started shares of Whiting with a Buy rating and $66 target.
  
• Rodman & Renshaw initiated shares of Peregrine Pharma (NASDAQ:PPHM) with a Market Perform rating, as they would prefer to establish a position closer to mid-08 when key data from its Cotara Phase II study is expected.

• Stanford initiated Tercica (NASDAQ:TRCA) with a Buy rating and $10 target.
  
• Broadpoint initiated Pain Therapeutics (NASDAQ:PTIE) with an Underperform rating.
  
• Mattel (NYSE:MAT) was initiated with a Hold rating and $22 target at Citigroup.

Permalink | Email this | Linking Blogs | Comments

Jones Soda Co. today announced that Peter van Stolk will step down from his position as chairman of the board of directors and as chief executive officer at the end of the year. He will remain on as a member of the board of directors. Board members Scott Bedbury and Steve Jones will take on the interim positions of chairman and CEO respectively while the company conducts a search for a new CEO.

Marketing maverick Peter van Stolk has a unique, interactive approach to grounding his products, an intense connection to his consumers and an uncanny ability to predict trends. He entered the highly competitive beverage industry, learned the rules and then promptly rejected them. Peter has been able to attract attention by setting his products apart from the rest and developing an emotional bond with his customers....

Read | Permalink | Email this | Linking Blogs | Comments

For a bullish hedged play on this stock, I would consider a March bull-put credit spread below the $5 range. A bull-put credit spread is an options position that combines the purchase and sale of put options to hedge risk in case the stock doesn't do what you think but still leverage nice returns. For this particular trade, we will make an 11.1% return in just 3 and a half months as long as JSDA is above $5 at March expiration. Jones would have to fall by more than 18% before we would start to lose money.

JSDA hasn't been below $5 at all in the past year and has shown support around $5.95 recently. This trade could be risky if the excitement for investors has fully left this stock, but even if that happens, there could be a grace period for the new CEO who will start at the beginning of 2008.

Brent Archer is an options analyst and writer at Investors Observer. DISCLOSURE: Mr. Archer owns and/or controls diversified portfolios of long and short stock and option positions that may include holdings in companies he writes about. At publication time, Brent neither owns nor controls positions in JSDA.

Permalink | Email this | Linking Blogs | Comments

Permalink | Email this | Linking Blogs | Comments

Priceline (NASDAQ: PCLN)'s higher profits are taking shares up 14%. And Rio Tinto (NYSE: RTP) is up 9% on buyout rumors.

Jones Soda (NASDAQ: JSDA) is trading off 19% due to poor earnings. And Leap Wireless (NASDAQ: LEAP) is off 15% on news that it will have to restate earnings.

Douglas A. McIntyre is an editor at 247wallst.com

Permalink | Email this | Linking Blogs | Comments

Read | Permalink | Email this | Linking Blogs | Comments

Permalink | Email this | Linking Blogs | Comments

If the members of the board of directors at Jones Soda (NASDAQ: JSDA) weren't trading based on any kind of inside information, they may want to consider starting their own hedge funds. That's how good the timing of their sales was.

During an 85-day period this spring, 5 directors sold nearly all of their shares in the company. The stock is about 67% off the high it reached during that period. According to the Seattle-Post Intelligencer, "If the board members and executives had made the trades Monday, when the stock closed at $10.74 on the Nasdaq stock market, they would have gotten a combined $3.6 million, or 45 percent less than what they received."

CEO Peter van Stolk told the newspaper that the directors exercise options/sell stock as compensation for all their hard work. But the sales, and their uncanny timing, raise a question: If the outside directors were so involved in the management of the company, wouldn't they have been aware of the problems the company was having that led to the demise of the share-price?

Industry experts are questioning the timing of the sales, but maybe we should give them the benefit of the doubt: Even after the sell-off, the stock is trading at 114 times earnings. The stock had been on a tear, and you can hardly blame them for wanting to take some profits... or all their profits.

Regardless of whether the Jones directors were trading inappropriately -- I won't speculate -- this raises an interesting question: What is an executive or director supposed to do when he feels that his company's stock is overvalued? Does she have some moral obligation to hold the stock, or should she try to dump it before it plummets as investor exuberance subsides?

Ultimately, investors should be more worried about the performance of a company than director sales. And given the stock's recent chart, there's plenty of complaining to be done on that front.

Read | Permalink | Email this | Linking Blogs | Comments

Coca-Cola Co. (NYSE: KO) and PepsiCo Inc. (NYSE: PEP), which are betting that people's thirst for bottled water will continue to grow, would probably prefer that the public ignore an experiment that Penn and Teller did on their Showtime series a few years ago.

Using hidden cameras, the magicians videotaped unsuspecting people at a restaurant who were being served glasses of what they thought were expensive bottled water by a steward. What they didn't know was that their beverage came from a hose. The program is called "Penn and Teller [explicative deleted]," which is exactly how I feel about the bottled water business.

The hype around popular brands, including Vitaminwater, whose corporate parent Glaceau Coke recently agreed to buy for $4.2 billion, fizzes upon closer inspection.

While there are people with bad water and unsafe water, most Americans have perfectly fine water coming out of their taps. In fact, as FastCompany points out, the two leading brands, Pepsi's Aquafina and Coke's Dasani, are purified municipal water. The Natural Resources Defense Council and other experts have repeatedly pointed out that bottled water isn't as strictly regulated as tap water. An NRDC study actually found that 33% of the waters it tested "violated an enforceable state standard or exceeded microbiological-purity guidelines, or both, in at least one sample."

"There are very few differences between the health benefits of bottled and tap water except in isolated circumstances," said Greg Kail, a spokesman for the American Water Works Association, a trade group representing operators of water systems, in an interview. "In North America, we all enjoy some of the safest drinking water in the world."

None of this matters to most bottled water consumers, who are convinced that the H2O in the small plastic jugs that they buy in their supermarket and convenience stores is better for them. It certainly is convenient, which is why I buy some of the stuff myself. There is plenty of room for the industry to grow.

Kim Jeffrey, the CEO of Nestle SA (OTC: NSRGY)'s water business in North America, who oversees US sales of Perrier, San Pellegrino and Poland Spring worth about $4.5 billion this year, told FastCompany that the bottled water business is only about half of the size of the carbonated beverage industry -- but with only 15% of its marketing budget.

That's remarkable considering how much water sales are rising while soda sales are falling. An exception to the rule has been Hansen Natural Corp. (NASDAQ: HANS), whose stock has jumped more than 36% this year. Hansen recently signed a distribution deal with Anheuser-Busch Cos. (NYSE: BUD), which like the soda makers is struggling to revive flagging sales. The stock of another trendy soda company, Jones Soda Co. (NASDAQ: JSDA), has soared more than 41% this year even though it was dropped by Starbucks Corp. (NASDAQ: SBUX).

So look for more over-priced, over-hyped beverages to come to your grocer's cooler soon and for big companies to continue to snap up the companies that make them.

More Vitamin Water news

Beth Gaston Moon: High school vending machines getting more eclectic
Zac Bissonnette: PepsiCo plans a lower-calorie Gatorade
Zac Bissonnette: Experts doubt Snapple will satisfy Coke
Zac Bissonnette: Will Coca-Cola gulp down Snapple?
Joseph Lazzaro: Coke's catching up in the health drink segment
Zac Bissonnette: Coke swallows Vitaminwater
Zac Bissonnette: Coke wants vitamin water
Zac Bissonnette: Coke Zero is no zero, it's a big hit
Sarah Gilbert: Fuze acquisition pits Coke v. Pepsi in ritzy juice war

Read | Permalink | Email this | Linking Blogs | Comments

MOST NOTEWORTHY:

• JP Morgan upgraded shares of Tektronix (NYSE: TEK) to Overweight from Underweight citing improving sector fundamentals.

• JP Morgan also raised GameStop (NYSE: GME) to Overweight from Neutral based on the May sales data.

• Oppenheimer upgraded PrivateBancorp (NASDAQ: PVTB) to Neutral from Sell based on valuation.

• BMO Capital raised Quebecor World (NYSE: IQW) to Market Perform from Underperform on valuation.

• CheckFree (NASDAQ: CKFR) was assumed with a Sector Outperformer from Sector Performer at CIBC citing a favorable risk/reward, solid secular underlying trends, and overblown concerns for its rating...

• Symantec Corp (NASDAQ: SYMC) was upgraded to Buy from Neutral at Goldman.

• Ingersoll-Rand Co Ltd (NYSE: IR) was raised to Outperform from Peer Perform at Bear Stearns.

• ThinkEquity upgraded shares of Jones Soda Co (NASDAQ: JSDA) to Buy from Accumulate.

• BB&T upgraded Pacific Sunwear of California (NASDAQ: PSUN) to Buy from Hold.

• Goldman added Cigna Corp (NYSE: CI) to its America's Conviction List.

Permalink | Email this | Linking Blogs | Comments

Read | Permalink | Email this | Linking Blogs | Comments

Jones Soda Company (NASDAQ: JSDA) has lost whatever fizz it might have had as an investment and is in the process of losing its identity as a brand. Yes, it was a big deal when quirky Jones Soda beat out Coca-Cola (NYSE: KO) to be the soft drink of choice for the Seattle Seahawks at their stadium. But such a venue may be the wrong place to sell a soda that made a name for itself precisely because it marketed unfamiliar flavors in unfamiliar (and somewhat undesirable) locations such as tattoo and piercing parlors, grunge cafes and slacker parks. And yes, it was nice that customers could send in a picture of their mutt as a possible bottle label. But if it wishes to play in the big leagues, Jones will have to come up with some version of a Coke-like flavor to serve to stadium customers who, just because they must buy the product at the game, may not be willing to shell out premium soda prices for Jones' products at the grocery store. And just exactly what is Jones Soda doing for sale at Wal-Mart (NYSE: WMT)? Is Jones Soda now going to market itself as a value-priced soda, except with weird flavors?

Jones Soda cannot seem to settle on a business model, cannot figure out what it wants to be when it grows up. I suggest it might be time to think about becoming a profitable company. The number of cases of soda sold in 1Q 2007 doubled to 1.72 million. But revenue increased by 5% while EPS was ZERO, the same as it was in 1Q 2006. Sell more product, make less money. Counter-intuitive marketing campaigns can be very effective, but at some point Jones Soda must show some ROI to justify its current P/E multiple of 101.09, 400% above the industry average.

Permalink | Email this | Linking Blogs | Comments

Permalink | Email this | Linking Blogs | Comments

New York's Major League Soccer team is owned - and named after - Red Bull. Xyience is the drink of choice at the UFC. Gatorade, a unit of PepsiCo (NYSE: PEP) is an official sponsor of the NFL.

Earlier today, Jones Soda Co (NASDAQ: JSDA) said it would be a sponsor of the NFL's Seattle Seahawks on CNBC. The Seahawk organization granted Jones the exclusive soft-drink and certain non-alcoholic beverage availability rights at Qwest and Events Center as well as other sponsorship and trademark rights regarding the use of the Seahawks trademarks through 2012.

The world of alternative beverages continues to gain notoriety and Jones' deal with the Seattle Seahawks is a big step not only for the company but for the sector. Shares of Jones Soda closed up 8.25%, to $21.64 today.

I wonder if Jones would make an exclusive drink to promote the deal. They could call it Seattle Sludge, perhaps? How about Football Fudge?

Permalink | Email this | Linking Blogs | Comments